Imbruvica (ibrutinib)
pCPA File Number:
22541
Negotiation Status:
Under consideration for negotiation
Indication(s):
Waldenström’s macroglobulinemia
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
PC0328-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable